Trending...
- KLEKT Announces Appointment of Jay Kimpton to Board of Directors
- Tacoma City Council Restricts Unauthorized Use of Public Property for Civil Immigration Enforcement
- Spokane: DUI Driver Taken Into Custody After Attempting to Flee from Officers
SEATTLE ~ AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been awarded a special mention for Research and Innovation led by Executives Under the Age of 40 by Confindustria. Confindustria is the main association representing manufacturing and service companies in Italy, with a voluntary membership of more than 150,000 companies of all sizes, employing a total of 5,383,286 people.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
- Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
- Tacoma: City Council Takes Steps to Further Activate and Support High-Investment Corridors
- NewReputation's AI Sentiment Analysis Tool Reaches 2,500 Users as Businesses Demand Clearer Brand Intelligence
- CAPO Supply Announces Opening of Second Location in New Castle, Pennsylvania
- $224 Billion Growing Market in Life Settlements Presents Major Opportunity for New Policy Acquisition Business Plan: DLT Resolution Stock Symbol: DLTI
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
0 Comments
Latest on Washingtoner
- Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
- Integrated Maintenance Platforms Are Transforming Aircraft Operations
- T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
- Derek Advanced Tracking Systems Revolutionizes Asset Monitoring with Advanced Technology
- The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
- Spokane: Flags Lowered for Peace Officers Memorial Day
- $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH
- All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
- iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
- Inside-Out Hollywood: The Relentless Rise of Joseph Nybyk (AKA Joseph Neibich)
- Lumetra Launches Engram, an MCP-Native Memory Layer Scoring 91.6% on LongMemEval
- Spokane Parks & Recreation's Therapeutic Recreation Receives Donation
- SRK Collective Media Group Launches with a Modern Approach to Media, Authority Building, and Cultural Visibility
- MSBG Corporation Acquires GridWatch US Telemetry Automation System
- TAYP Expands Athlete Exposure Platform Beyond Georgia With New Push Into Virginia and the 757
- KT Medical Staffing Expands Concierge Nursing and Private Duty Nursing Services in Orange County
- The Millennium Alliance Achieves Great Place To Work® Certification™ Amid Continued Growth
- The Millennium Alliance Appoints Former Adweek Executive Eric Hayden Shakun as Chief Financial Officer to Accelerate Next Phase of Growth
- North Puget Sound League Launches New Player Development Academy (PDA) Tryouts
- T. Jones Group Named Finalist Across Multiple Categories at the 2026 Georgie Awards